Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 7 - Drugs for disorders of the blood or the extracellular fluid
Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065)
11/1999
11/30/1999US5994127 In vivo production and delivery of erythropoietin or insulinotropin for gene therapy
11/30/1999US5993816 Methods to inhibit humoral immune responses, immunoglobulin production and B cell activation with 5c8-specific antibodies
11/30/1999US5993815 Methods and compositions for inhibiting the activation of thrombin-activatable fibrinolysis inhibitor (TAFI)
11/30/1999US5993807 Truncated aspartase enzyme derivatives and uses thereof
11/30/1999US5993801 Gene therapy using stromal cells
11/30/1999CA2079077C Tissue glue prepared by using cryoprecipitate
11/30/1999CA2019035C Stabilized radiopharmaceutical compositions
11/25/1999WO1999060126A2 Protein z-dependent protease inhibitor
11/25/1999WO1999060020A1 Secreted proteins and polynucleotides encoding them
11/25/1999WO1999060018A1 Labelled glutamine and lysine analogues
11/25/1999WO1999059966A1 METHOD OF LOCKING 1α-OH OF VITAMIN D COMPOUNDS IN AXIAL ORIENTATION
11/25/1999WO1999059964A1 Novel analogs of 16-hydroxyeicosatetraenoic acid
11/25/1999WO1999059811A1 Multi-action particle for structuring biological media
11/25/1999WO1999059631A1 Prevention and treatment of hypergastrinemia
11/25/1999WO1999059611A1 Compositions and methods for prevention and treatment of uncontrolled formation of intravascular fibrin clots
11/25/1999WO1999059606A1 Use of rosmarinic acid and derivatives thereof as an immunosuppressant or an inhibitor of sh2-mediated process
11/25/1999WO1999059602A1 Novel pharmaceutical composition for use in emergency treatment and preparation method thereof
11/25/1999WO1999059591A1 Pyrazinone thrombin inhibitors
11/25/1999WO1999050249A3 Pyrimidines and triazines as integrin antagonists
11/25/1999WO1999047545A3 Inhibitors of caspases
11/25/1999WO1998041226A9 Pharmaceutical combined preparations containing erythropoietin and iron preparations
11/25/1999CA2333103A1 Method of locking 1.alpha.-oh of vitamin d compounds in axial orientation
11/25/1999CA2332803A1 Multi-action particle for structuring biological media
11/25/1999CA2332277A1 Labelled glutamine and lysine analogues
11/25/1999CA2332272A1 Novel analogs of 16-hydroxyeicosatetraenoic acid
11/25/1999CA2330471A1 Compositions and methods for prevention and treatment of uncontrolled formation of intravascular fibrin clots
11/25/1999CA2329914A1 Pyrazinone thrombin inhibitors
11/25/1999CA2328605A1 Protein z-dependent protease inhibitor
11/25/1999CA2328501A1 Prevention and treatment of hypergastrinemia
11/25/1999CA2328489A1 Secreted proteins and polynucleotides encoding them
11/24/1999EP0958366A1 Human chemokine beta-13
11/24/1999EP0958287A1 Sulfamide-metalloprotease inhibitors
11/24/1999EP0958283A1 New compounds with hemoregulating effect
11/24/1999EP0958282A1 2-amino-6-(2-substituted-4-phenoxy)-substituted-pyridines
11/24/1999EP0957918A1 Method of treating or inhibiting neutropenia
11/24/1999EP0957908A1 Fibrinogen receptor antagonists
11/24/1999EP0957907A1 Il-8 receptor antagonists
11/24/1999CN1236358A Substituted N-[(aminoiminomethyl or aminomethyl) phenyl] propyl amides
11/24/1999CN1235968A Substituted tricyclics
11/24/1999CN1235833A Novel drug composition for treating and curing and its preparing method
11/24/1999CN1046731C Pyrrolo [2,3-d] pyrimidines and their use
11/24/1999CN1046724C Pyrazolopyridine compounds, pharmaceutical containing them, and its preparing method and use
11/24/1999CN1046710C aminopyridines, process for preparing the same and use and medicaments containing the same
11/24/1999CN1046635C Composition and mether using nitrooxides to avoid oxygen toxicity
11/23/1999US5990241 Polyoxypropylene/polyoxyethylene copolymers with improved biological activity
11/23/1999US5990148 Side effect reductions; antiarthritic agents; nonsteroidal antiinflammatory agents
11/23/1999US5990079 Agents affecting thrombosis and hemostasis
11/23/1999US5989578 Associations of active principles containing clopidogrel and an antithrombotic agent
11/23/1999US5989538 Mpl ligand analogs
11/23/1999US5989537 Methods for stimulating granulocyte/macrophage lineage using thrombopoietin
11/23/1999CA2103680C Improved blood substitute
11/18/1999WO1999058699A2 Transgenic plant-derived human blood coagulation factors
11/18/1999WO1999058680A2 Method for diagnosis and treatment of haemophilia a patients with an inhibitor
11/18/1999WO1999058642A2 Secreted proteins and polynucleotides encoding them
11/18/1999WO1999058572A1 Binding molecules derived from immunoglobulins which do not trigger complement mediated lysis
11/18/1999WO1999058569A1 PLASMIN INHIBITORS FROM THE AUSTRALIAN BROWN SNAKE $i(PSEUDONAJA TEXTILIS TEXTILIS)
11/18/1999WO1999058531A1 Novel substituted aryl hydroxamic acids as metalloproteinase inhibitors
11/18/1999WO1999058528A1 Substituted aryl hydroxamic acids as metalloproteinase inhibitors
11/18/1999WO1999058523A1 1,5-DIARYL SUBSTITUTED PYRAZOLES AS p38 KINASE INHIBITORS
11/18/1999WO1999058502A1 Heterocyclic inhibitors of p38
11/18/1999WO1999058140A1 Methods to increase white blood cell survival after chemotherapy
11/18/1999WO1999058098A2 HUMAN ANTITHROMBIN IIIs AND METHODS RELATED THERETO
11/18/1999WO1999050255A3 Disubstituted pyrazolines and triazolines as factor xa inhibitors
11/18/1999WO1999046281A9 Novel polypeptides and nucleic acids encoding the same
11/18/1999WO1999027098A3 A-33 related antigens and their pharmacological uses
11/18/1999CA2331878A1 1,5-diaryl substituted pyrazoles as p38 kinase inhibitors
11/18/1999CA2330108A1 Novel substituted aryl hydroxamic acids as metalloproteinase inhibitors
11/18/1999CA2330095A1 Substituted aryl hydroxamic acids as metalloproteinase inhibitors
11/18/1999CA2328493A1 Transgenic plant-derived human blood coagulation factors
11/18/1999CA2328397A1 Human antithrombin iiis and methods related thereto
11/18/1999CA2328062A1 Secreted proteins and polynucleotides encoding them
11/17/1999EP0956860A1 Hematopoietic function restorative and processed food both containing treated peanut testae
11/17/1999EP0956294A1 Thrombin inhibitors
11/17/1999EP0956049A2 Conjugates of thrombin inhibitors and endogenes carriers
11/17/1999CN1235597A Heterocycle derivatives inhibiting factor Xa
11/17/1999CN1235596A Cyclic amine derivatives
11/17/1999CN1235551A Pharmaceutical composition for diabetes
11/17/1999CN1235518A Cocoa components, edible products having enhanced polyphenol content, methods of making same and medical use
11/17/1999CN1235156A New benzothiophene, benzofuran and indole compounds, process for their preparation and pharmaceutical compounds containing them
11/17/1999CN1235048A Prescription of Tongshuanhuoluowan as medicine for thrombolysis and activating collaterals and preparing method thereof
11/17/1999CN1235028A Chinese medicine for argiitis
11/16/1999US5986069 Human haemopoietic maturation factor polypeptides
11/16/1999US5986065 Antibodies for inhibiting blood coagulation and methods of use thereof
11/16/1999US5986049 Purification by applying a biological fluid to polypeptide support,washing, elution, fractionation and accumulation
11/16/1999US5985902 Substituted isoxazole for the treatment of inflammation
11/16/1999US5985332 Hemoglobins provided with ligands protecting the oxygen binding sites for use as artificial oxygen carriers for direct application in medicine and biology, and method for the preparation thereof
11/16/1999US5985279 Humanized antibody against CD18
11/16/1999US5985265 Attaching a polyethylene glycol molecule to a consensus interferon molecule via reductive alkylation.
11/16/1999CA2088761C Benzimidazole derivatives, process for their preparation and application
11/11/1999WO1999057301A1 Compounds having glucuronic acid derivatives and glucosamine derivatives in the structure, process for producing the same and utilization thereof
11/11/1999WO1999057291A1 Genomic sequences upstream of the coding region of the g-csf gene for protein production and delivery
11/11/1999WO1999057290A1 Molecular regulatory circuits to achieve sustained activation of genes of interest by a single stress
11/11/1999WO1999057288A1 Endothelin-converting-enzyme like protein
11/11/1999WO1999057251A2 Thrombolytic agents derived from streptokinase
11/11/1999WO1999057113A1 Heterocyclic derivatives which inhibit factor xa
11/11/1999WO1999057112A1 Reduced particle size form of 1-(6-chloronaphth-2- ylsulphonyl) -4-[4-(4pyridyl) benzoyl] piperazine
11/11/1999WO1999057099A1 Heterocyclic derivatives which inhibit factor xa
11/11/1999WO1999057096A1 Biphenyl derivatives
11/11/1999WO1999056753A1 Hematopoietic stimulation
11/11/1999CA2331122A1 Hematopoietic stimulation
1 ... 531 532 533 534 535 536 537 538 539 540 541 542 543 544 545 546 547 548 549 550 551 ... 671